ECMO Braile Biomédica® in COVID-19 Patients

计划入组 30 人 · 首次发布于 2023 年 10 月 17 日

ANATOMICAL FEASIBILITY OF BRAILE STANDARD BRANCHED ENDOGRAFT

计划入组 100 人 · 首次发布于 2025 年 8 月 12 日

Aortic or Mitral Valve Replacement With the Braile Biomédica® Bovine Pericardium Valvular Bioprosthesis

计划入组 913 人 · 首次发布于 2023 年 6 月 15 日

CYP17 inhibitors (Angion Biomedica)

ANG-3563

ATP7B gene therapy (Oxford Biomedica)

Osteros Biomedica Ltd.

Russia

Oxford Biomedica (UK) Ltd.

United Kingdom

Angion Biomedica Corp.

United States

Zydus MedTech Partners with Braile Biomedica to Expand TAVI Technology Across Europe and India

Oxford Biomedica Expands US Gene Therapy Manufacturing with $4.5M North Carolina Facility Acquisition

Oxford BioMedica Achieves Full Ownership of US Subsidiary to Strengthen Global Gene Therapy Manufacturing Network